20.48
3.98%
-0.85
시간 외 거래:
20.48
전일 마감가:
$21.33
열려 있는:
$21.31
하루 거래량:
184.62K
Relative Volume:
1.14
시가총액:
$780.18M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+1.69%
1개월 성능:
-5.84%
6개월 성능:
+0.00%
1년 성능:
+0.00%
Rapport Therapeutics Inc Stock (RAPP) Company Profile
명칭
Rapport Therapeutics Inc
전화
857-321-8020
주소
1325 BOYLSTON STREET, BOSTON
Rapport Therapeutics Inc 주식(RAPP)의 최신 뉴스
Perceptive Advisors LLC Invests $17.40 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Shares Up 6.2% - MarketBeat
(RAPP) Technical Data - Stock Traders Daily
ARCH Venture Management LLC Makes New $86.73 Million Investment in Rapport Therapeutics (NASDAQ:RAPP) - Defense World
ARCH Venture Management LLC Invests $86.73 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Biogen, Alnylam-partnered Camp4 Therapeutics unveils IPO plans - The Business Journals
Rapport Therapeutics Inc. (RAPP) rating initates by TD Cowen - Knox Daily
Rapport Therapeutics (NASDAQ:RAPP) Shares Down 2.4% - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Up 4.7% - Defense World
Reckitt shares up on report of potential homecare asset sale By Investing.com - Investing.com South Africa
Rhythm Pharmaceuticals initiated with a Buy at H.C. Wainwright - TipRanks
Quest Partners LLC Sells 5,882 Shares of iRobot Co. (NASDAQ:IRBT) - Defense World
Sofinnova Investments Inc. Invests $45.39 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Trading 4.7% Higher - MarketBeat
RNAZ’s Financial Health: Exploring TransCode Therapeutics Inc’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle
Trimble and Platform Science pushed hard to get deal done before Vegas meeting - Yahoo Finance
Johnson & Johnson Invests $58.11 Million in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $19.00 - MarketBeat
(RAPP) Trading Advice - Stock Traders Daily
TD Asset Management Inc Takes Position in Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
TD Asset Management Inc Invests $2.36 Million in Rapport Therapeutics (NASDAQ:RAPP) - Defense World
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 5.5% - MarketBeat
The Potential Rise in the Price of Rapport Therapeutics Inc. (RAPP) following insiders activity - Knox Daily
IPO class of 2024 shows value recovery despite mixed stock performance - BioWorld Online
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $21.20 - MarketBeat
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences - GlobeNewswire
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences - StockTitan
Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences - Yahoo Finance
Rapport Therapeutics (NASDAQ:RAPP) Trading Up 5.8% - MarketBeat
Market Insights: Rapport Therapeutics Inc. (RAPP)’s Notable Gain of 9.85, Closing at 21.75 - The Dwinnex
Investing in Rapport Therapeutics Inc. (RAPP): What You Must Know - Knox Daily
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $20.40 - Defense World
Rapport Therapeutics to Present at 22nd Annual Morgan - GlobeNewswire
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit - StockTitan
Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen’s 4th Annual Novel Mechanisms in Neuropsychiatry Summit - Yahoo Finance
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Up to $20.40 - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Stock Price Down 4.4% - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Trading 3.8% Higher - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Trading Up 2.5% - MarketBeat
(RAPP) Investment Report - Stock Traders Daily
Stifel reiterates buy rating on Rapport Therapeutics shares, keeps $35 PT - Investing.com Canada
Rapport Therapeutics (NASDAQ:RAPP) Trading Down 2.5% - MarketBeat
The 3 Best Healthcare Stocks to Buy in August 2024 - InvestorPlace
Rapport Therapeutics (NASDAQ:RAPP) Shares Up 10.2% - MarketBeat
Contineum Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights - Business Wire
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Down to $18.56 - Defense World
Rapport Therapeutics (NASDAQ:RAPP) Shares Gap Down to $18.56 - MarketBeat
Rapport Therapeutics (NASDAQ:RAPP) Hits New 12-Month Low at $16.80 - MarketBeat
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update - GlobeNewswire
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update - WDRB
Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update - Yahoo Finance
Rapport Therapeutics Inc (RAPP) 재무 분석
Rapport Therapeutics Inc (RAPP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):